ACR/AAHKS: DMARDs Can Be Used in Perioperative Management of Hip and Knee Replacement Surgery

DMARDs
Should synthetic (non-biologic) disease-modifying antirheumatic drugs (sDMARDs) be withheld during perioperative period of patients undergoing elective replacement surgery of the hip or knee…

Read more: ACR/AAHKS: DMARDs Can Be Used in Perioperative Management of Hip and Knee Replacement Surgery

Reference: Goodman, Susan M., et al. "2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. The Journal of Arthroplasty (2017).

Long-term Treatment of Osteoporosis with Denosumab: Is It a Good Idea?

Osteoporosis
Denosumab is considered to be a promising therapeutic option for osteoporotic patients, since the FREEDOM study showed us that treatment with denosumab for 3 years had made it possible to…

Read more: Long-term Treatment of Osteoporosis with Denosumab: Is It a Good Idea?

Reference: Bone, Henry G., et al. "10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension." The Lancet Diabetes & Endocrinology (2017).

Intra-articular Corticosteroid Injections Increase Cartilage Loss in Knee Osteoarthritis

MRI Knee OA
Symptomatic knee osteoarthritis is a disabling joint disease that affects many people. Studies have shown the presence of synovitis in the joints affected by osteoarthritis and have…

Read more: Intra-articular Corticosteroid Injections Increase Cartilage Loss in Knee Osteoarthritis

Reference: McAlindon, Timothy E., et al. "Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial." Jama 317.19 (2017): 1967-1975.

More Articles ...